Analystreport

Caris Life Sciences (CAI) is now covered by The Goldman Sachs Group, Inc.. They set a "buy" rating and a $27.00 price target on the stock.

Caris Life Sciences, Inc.  (CAI) 
Last caris life sciences, inc. earnings: 10/29 04:00 pm Check Earnings Report
US:NYSE Investor Relations: investor.capps.com/investor-relations